. 2020 Mar 11;9(1):45–54. doi: 10.1093/toxres/tfaa002

Table 6.

Comparison between the four studied GPs according to management

Management	GP I (n = 15)		GP II (n = 15)		GP III (n = 15)		GP IV (n = 15)		Test of significance	P
Management	No.	%	No.	%	No.	%	No.	%	Test of significance	P
Total IV fluids in 24 h
Min.–Max.	2.0–3.50		1.50–3.50		1.50–3.50		1.50–3.0		F = 7.026^*	<0.001^*
Mean ± SD	2.97 ± 0.52		2.27 ± 0.53		2.70 ± 0.46		2.23 ± 0.56		F = 7.026^*	<0.001^*
P_control			0.003^*		0.498		0.002^*
Significance between GPs			P ₁ = 0.112, P₂ = 0.998, and P₃ = 0.076
Anti-emetic (ondansetron 4 mg)
Min.–Max.	8.0–24.0		4.0–12.0		4.0–24.0		1.50–3.0		H = 43.662^*	<0.001^*
Mean ± SD	14.67 ± 4.19		8.53 ± 2.56		12.8 ± 4.83		2.23 ± 0.56		H = 43.662^*	<0.001^*
P_control			0.003^*		0.390		<0.001^*
Significance between GPs			P ₁ = 0.039^, P₂ = 0.002^, and P₃ < 0.001^*

Pairwise comparison between each two GPs was carried out using post hoc test (Tukey). χ², chi square test; MC, Monte Carlo; H, H for Kruskal–Wallis test; F, F for ANOVA test.